Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2007; 132(25/26): 1373-1375
DOI: 10.1055/s-2007-982037
DOI: 10.1055/s-2007-982037
Klinischer Fortschritt | Commentary
© Georg Thieme Verlag KG Stuttgart · New York
Nephrologie 2007
Nephrology 2007Further Information
Publication History
eingereicht: 21.5.2007
akzeptiert: 24.5.2007
Publication Date:
15 June 2007 (online)

Was ist neu?
-
Zystennieren: Endlich Therapiemöglichkeiten?
-
Nephrogene systemische Fibrose: Zusammenhang mit Gadolinium?
Literatur
- 1
Biance S, Bigazzi R, Campese V M.
Long term effects of spironolacton on proteinuria and kidney function in patients
with chronic kidney disease.
Kidney Int.
2006;
70
2116-2123
MissingFormLabel
- 2
Bukanov N O et al.
Long lasting arrest of murine cystic kidney disease with CDK inhibitor roscoviten.
Nature.
2006;
444
949-952
MissingFormLabel
- 3
Drueke T B, Locatelli F, Clyne N. et al .
Normalization of hemoglobin level in patients with chronic kidney disease and anemia.
N Engl J Med.
2006;
355
2071-2084
MissingFormLabel
- 4
Epstein M, Williams G H. et al .
Selective aldosteron blockade with eplerenone reduces albuminuria in patients with
Type 2 diabetes.
Clin J Am Soc Nephrol.
2006;
1
940-951
MissingFormLabel
- 5
Grobner T.
Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy
and nephrogenic systemic fibrosis?.
Nephrol Dial Transplant.
2006;
21
1104-1108
MissingFormLabel
- 6
Hoste E A, Clermont G. et al .
RIFLE criteria for acute kidney injury are associated with hospital mortality in critically
ill patients: a cohort analysis.
Crit Care.
2006;
10
R73
MissingFormLabel
- 7
Liu K D, Himmelfarb J, Paganini E. et al .
Timing of initiation of dialysis in critically ill patients with acute kidney injury.
Clin J Soc Am Nephrol.
2006;
1
915-919
MissingFormLabel
- 8
Marckmann P, Skov L, Rossen K. et al .
Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced
magnetic resonance imaging.
J Am Soc Nephrol.
2006;
17
2359-2362
MissingFormLabel
- 9
Marenzi G, Assanelli F, Marana I. et al .
N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.
N Engl J Med.
2006;
354
2773-2782
MissingFormLabel
- 10
Rocco M V, Frankenfield D L, Hopson S D, McClellan W M.
Relationship between clinical performance measures and outcomes among patients receiving
long term hemodialysis.
Ann Int Med.
2006;
145
512-519
MissingFormLabel
- 11
Singh A K, Szczech L, Tang K L. et al .
Correction of anemia with epoetin alfa in chronic kidney disease.
N Engl J Med.
2006;
355
2085-2098
MissingFormLabel
- 12
Uchino S. et al .
An assessment of the RIFLE criteria for acute renal failure in hospitalized patients.
Crit Care Med.
2006;
34
1913-1917
MissingFormLabel
- 13
Vinsonneau C, Camus C. et al .
Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute
renal failure in patients with multiple-organ dysfunction syndrome.
Lancet.
2006;
368
379-385
MissingFormLabel
- 14
Wattanakit K, Coresh . et al .
Cardiovascular risk among adults with chronic kidney disease, with or without prior
myocardial infarction.
J Am Coll Cardiol.
2006;
48
1183-1189
MissingFormLabel
- 15
Wattanakit K. et al .
Kidney function and risk of peripheral arterial disease: Results from the atherosclerosis
risk in community (ARIC) studies.
J Am Soc Nephrol.
2007;
18
629-636
MissingFormLabel
Prof. Dr. med. Christian Hugo
Medizinische Klinik 4, Universität Erlangen-Nürnberg
Krankenhausstraße 12
91054 Erlangen
Phone: 09131/8536028
Fax: 09131/8539209
Email: christian.hugo@rzmail.uni-erlangen.de